Veristat is Drug Discovery in United States that focus on medical device business. Founded in 1994. They cover business area such as provider, pharmaceutical, biotechnology, medical device, company, comprehensive clinical development service, biostatistic, statistical programming, medical writing, clinical monitoring, project management, data, a single study, an entire clinical program, its client, complex challenge, therapy, regulatory approval.
1994
( 30 years old in 2024 )
Medical Device
-
134 Turnpike Road
Suite 200
Southborough, MA 01772
United States
Private
providerpharmaceuticalbiotechnologymedical devicecompanycomprehensive clinical development servicebiostatisticstatistical programmingmedical writingclinical monitoringproject managementdataa single studyan entire clinical programits clientcomplex challengetherapyregulatory approval
* We use standard office opening hours in near Veristat's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Veristat is Drug Discovery business from United States that founded in 1994 (30 years old in 2024), Veristat business is focusing on Medical Device.
Veristat headquarter office and corporate office address is located in 134 Turnpike Road Suite 200 Southborough, MA 01772 United States.
Veristat was founded in United States.
In 2024, Veristat is currently focus on medical device sector.
Above is snippet of Google Trends for "medical device" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Veristat, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
